Promising drug by UAlberta researchers could save millions of lives.
Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.
Heart specialist Gavin Oudit and his research team discovered a molecule—angiotensin converting enzyme 2 (ACE2)—that works to restore balance to the pathways responsible for chronic and acute heart failure, including in patients with advanced heart failure who underwent heart transplants.
In conducting their research, Oudit and his team used genetic mapping technology to discover to an extent not seen before how the renin-angiotensin system (RAS)—which regulates the body’s sodium balance, fluid volume and blood pressure—is at play in both acute and chronic heart failure.
It led to the creation of recombinant human ACE2, a new drug that was manufactured by Apeiron Biologics in collaboration with Oudit. It was bought by GlaxoSmithKline, which recently successfully completed phase II clinical trials that tested for the safety and efficacy of the drug on hundreds of patients. The new drug is expected to be on the market in the next three to five years.
Oudit added that using mapping technology has also made it possible to individualize the dose a patient needs, allowing for a truly personalized treatment plan for heart failure patients in the future. The study also broke ground by showing how ACE2 can be used in heart transplant patients with heart failure.
About six million Canadians will develop heart failure, a common condition that most often happens after the heart has been damaged or weakened by heart attack or stroke. According to the Canadian Heart and Stroke Foundation, the two most common causes of heart failure are heart attacks and high blood pressure. When someone has heart failure, the heart either can’t accept the inflow of blood or pump it out, or both.
“This research is a terrific example of how the university works together synergistically to develop world-class research and translate that into medicines that impact patient outcomes,” added Oudit.
Learn more: New hope for treating heart failure
Receive an email update when we add a new ARTIFICIAL SYNAPSES article.
The Latest on: Heart failure
via Google News
The Latest on: Heart failure
- Congestive Heart Failure (CHF) Treatment Devices Market Analysis by Key Players, End Users, Application and CAGR Value Forecast to 2028on November 19, 2019 at 9:43 pm
Nov 20, 2019 (WiredRelease via COMTEX) -- “Global Congestive Heart Failure (CHF) Treatment Devices Market” report includes the world’s crucial region market share, size (volume), recent trends ...
- Biofourmis teams up with Novartis to commercialize a digital therapeutics platform for heart failure patientson November 19, 2019 at 7:20 am
Biofourmis struck a deal with pharma giant Novartis to commercialize digital therapeutics (DTx) for monitoring heart failure patients.
- Medication and lifestyle changes could be as effective as surgery for heart disease, trial findson November 18, 2019 at 9:13 pm
The results of a large heart disease trial could be a game changer for patients with coronary artery disease. Researchers found when it comes to preventing heart attack or stroke, getting a stent or ...
- New, old drugs may offer fresh ways to fight heart diseaseon November 18, 2019 at 5:26 pm
The first few of these "RNA-interference" drugs recently were approved for other conditions, and research is also targeting heart disease. Farthest along is inclisiran, tested in 1,561 people with ...
- Both old and new drugs may offer fresh ways to fight heart diseaseon November 18, 2019 at 3:17 pm
For example, they can hinder cells’ ability to allow cholesterol to accumulate. The first few of these “RNA-interference” drugs recently were approved for other conditions, and research is also ...
- Novel Drugs May Offer New Ways to Fight Heart Diseaseon November 18, 2019 at 1:19 pm
Novel Drugs May Offer New Ways to Fight Heart Disease By MARILYNN MARCHIONE, AP Chief Medical Writer PHILADELPHIA (AP) — Doctors are reporting that novel drugs may offer fresh ways to reduce heart ...
- Entresto, Corlanor are widely used, cost-effective options for heart failure, study findson November 18, 2019 at 8:54 am
Nov. 18 (UPI) --Two fairly new medications for heart failure have become staples for those who receive Medicare benefits and are "cost-effective" options, an analysis published Monday in the journal ...
- Women with diabetes at greater risk of heart diseaseon November 18, 2019 at 8:15 am
Diabetes might be more deadly for women than men, at least when it comes to heart troubles, new research shows. Heart disease occurs an average of 15 years earlier in people with diabetes, and is ...
- This Diet Could Lower Your Risk of Heart Disease by 32 Percenton November 18, 2019 at 8:09 am
Johns Hopkins University researchers monitored 10,000 adults for nearly 30 years—from 1987 to 2016—and found that those who ate more fruits and vegetables in line with a vegetarian diet had a lower ...
via Bing News